People: Amgen Inc (AMGN.OQ)

AMGN.OQ on NASDAQ Stock Exchange Global Select Market

12:48am IST
Change (% chg)

$-3.08 (-1.27%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Reese, David 

Mr. David M. Reese serves as Executive Vice President - Research and Development of the Company. Dr. Reese joined the Company in 2005 and has held leadership roles in development, medical sciences and discovery research. Dr. Reese was Senior Vice President, Translational Sciences and Oncology from 2017 to 2018 and Senior Vice President, Translational Sciences from 2015 to 2017. Prior to joining Amgen, Dr. Reese was director of Clinical Research for the Breast Cancer International Research Group from 2001 to 2003 and a cofounder, president and chief medical officer of Translational Oncology Research International, a not-for-profit academic clinical research organization, from 2003 to 2005. Dr. Reese previously served on the faculty at University of California, Los Angeles, and the University of California, San Francisco.

Basic Compensation

Total Annual Compensation, USD 974,433
Restricted Stock Award, USD 2,799,710
Long-Term Incentive Plans, USD --
All Other, USD 2,763,780
Fiscal Year Total, USD 6,537,920

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 1,260 164,304.00